Search

everythinglearnresearchcommunity

for

Search:↓

Topical methotrexate is more effective and as safe as betamethasone for treating alopecia areata.

Combining methotrexate with low-dose prednisone is more effective for hair regrowth in alopecia areata totalis.

There are still challenges in diagnosing and treating chronic skin diseases, but there is hope for future improvements.

Baricitinib is more effective than methotrexate for severe alopecia areata.

Lupus can affect the scalp and nails, often causing hair loss and nail damage, and needs early aggressive treatment to prevent permanent damage.

Some treatments like intralesional steroids and 5α-reductase inhibitors are effective for frontal fibrosing alopecia, but more research is needed.

Lupus can cause hair loss and nail changes, with treatments available for both.

The document concludes that early diagnosis and a comprehensive treatment plan are crucial for managing hair loss in children, with a focus on both medical and psychological support.

Tofacitinib effectively regrows hair in alopecia areata patients, especially in younger individuals, with manageable side effects.

Compounded topical preparations should be used with caution for severe psoriasis and generally come after systemic treatments.

Manage vitiligo with treatments, address emotions, and use camouflage techniques.

JAK inhibitors show promise for treating skin disorders like alopecia, eczema, and psoriasis.

Guidelines suggest various treatments for alopecia areata, but leaving it untreated is also an option as 80% cases may recover on their own.

Pregnancy can cause various skin changes and diseases, with PUPPP being the most common skin condition specific to pregnancy.

Liposomal systems show promise for delivering drugs through the skin but face challenges like high costs and stability issues.

Patients with certain skin symptoms and high ANA titers should be monitored for potential systemic lupus.

The document concludes that skin biopsies, genetic and environmental factors, and specific treatments are important in managing cutaneous lupus erythematosus.

The document concludes that early recognition and treatment of primary cicatricial alopecia is crucial to prevent permanent hair loss.

Early diagnosis and treatment of discoid lupus erythematosus improve outcomes.

The document concludes that accurate diagnosis is crucial for effectively treating common scalp disorders, which often have similar symptoms.

A 5-year-old boy's skin condition improved with systemic valganciclovir after a cardiac transplant and immunosuppressive therapy.

Different types of hair loss in lupus need careful diagnosis for proper treatment.

Early diagnosis and treatment are crucial for preventing permanent hair loss in various scalp conditions, and while new treatments are promising, more research is needed to evaluate their effectiveness.

Most patients with frontal fibrosing alopecia stabilized with treatment, especially younger ones, using intralesional corticosteroids and tacrolimus.

Pregnancy can change skin disease severity, with some conditions improving and others worsening, and treatment should balance benefits and fetal safety.

KFSD is a genetic disorder causing hair loss and skin issues, with no effective treatment.

Patients with chronic skin conditions on systemic treatments did not have worse COVID-19 outcomes and could resume their treatments after recovery.

Older age at onset of alopecia areata leads to less severe and shorter episodes, with most patients experiencing significant hair regrowth.

New treatments for psoriasis have improved effectiveness and may reduce long-term side effects when combined with standard therapies.

The European Society of Cutaneous Lupus Erythematosus created a questionnaire to standardize patient assessment and improve care for cutaneous lupus.